-
1
-
-
67650874081
-
Cancer statistics, 2009
-
Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ,. Cancer statistics, 2009. CA Cancer J Clin 2009; 59: 225-49
-
(2009)
CA Cancer J Clin
, vol.59
, pp. 225-249
-
-
Jemal, A.1
Siegel, R.2
Ward, E.3
Hao, Y.4
Xu, J.5
Thun, M.J.6
-
2
-
-
63249122661
-
Mortality results from a randomized prostate-cancer screening trail
-
Andriole GL, Crawford ED, Grubb RL III, et al,. Mortality results from a randomized prostate-cancer screening trail. N Engl J Med 2009; 360: 1310-9
-
(2009)
N Engl J Med
, vol.360
, pp. 1310-1319
-
-
Andriole, G.L.1
Crawford, E.D.2
Grubb, III.R.L.3
-
3
-
-
63249118690
-
Screening and prostate-cancer mortality in a randomized European study
-
Schroder FH, Hugossson J, Roobol MJ, et al,. Screening and prostate-cancer mortality in a randomized European study. N Engl J Med 2009; 360: 1320-8
-
(2009)
N Engl J Med
, vol.360
, pp. 1320-1328
-
-
Schroder, F.H.1
Hugossson, J.2
Roobol, M.J.3
-
4
-
-
51649109226
-
Comparison of nomograms and other methods for predicting outcomes in prostate cancer: A critical analysis of the literature
-
Shariat SF, Karakiewicz PI, Suardi N, Kattan MW,. Comparison of nomograms and other methods for predicting outcomes in prostate cancer: a critical analysis of the literature. Clin Cancer Res 2008; 14: 4400-7
-
(2008)
Clin Cancer Res
, vol.14
, pp. 4400-4407
-
-
Shariat, S.F.1
Karakiewicz, P.I.2
Suardi, N.3
Kattan, M.W.4
-
5
-
-
60049096847
-
Prostate cancer: The new landscape
-
Moul JW, Mouraviev V, Sun L, Schroeck FR, Polascik TJ,. Prostate cancer: the new landscape. Curr Opin Urol 2009; 19: 154-60
-
(2009)
Curr Opin Urol
, vol.19
, pp. 154-160
-
-
Moul, J.W.1
Mouraviev, V.2
Sun, L.3
Schroeck, F.R.4
Polascik, T.J.5
-
6
-
-
67649713132
-
Management of localized prostate cancer in men over 65 years
-
Cooperberg MR, Konety BR,. Management of localized prostate cancer in men over 65 years. Curr Opin Urol 2009; 19: 309-14
-
(2009)
Curr Opin Urol
, vol.19
, pp. 309-314
-
-
Cooperberg, M.R.1
Konety, B.R.2
-
7
-
-
34447123124
-
Improved prediction of prostate cancer recurrence through systems pathology
-
DOI 10.1172/JCI31399
-
Cordon-Cardo C, Kotsianti A, Verbel DA, et al,. Improved prediction of prostate cancer recurrence through systems pathology. J Clin Invest 2007; 117: 1876-83 (Pubitemid 47036321)
-
(2007)
Journal of Clinical Investigation
, vol.117
, Issue.7
, pp. 1876-1883
-
-
Cordon-Cardo, C.1
Kotsianti, A.2
Verbel, D.A.3
Teverovskiy, M.4
Capodieci, P.5
Hamann, S.6
Jeffers, Y.7
Clayton, M.8
Elkhettabi, F.9
Khan, F.M.10
Sapir, M.11
Bayer-Zubek, V.12
Vengrenyuk, Y.13
Fogarsi, S.14
Saidi, O.15
Reuter, V.E.16
Scher, H.I.17
Kattan, M.W.18
Bianco Jr., F.J.19
Wheeler, T.M.20
Ayala, G.E.21
Scardino, P.T.22
Donovan, M.J.23
more..
-
8
-
-
50549102746
-
Systems pathology approach for the prediction of prostate cancer progression after radical prostatectomy
-
Donovan MJ, Hamann S, Clayton M, et al,. Systems pathology approach for the prediction of prostate cancer progression after radical prostatectomy. J Clin Oncol 2008; 26: 3923-9
-
(2008)
J Clin Oncol
, vol.26
, pp. 3923-3929
-
-
Donovan, M.J.1
Hamann, S.2
Clayton, M.3
-
9
-
-
67349084186
-
Personalized prediction of tumor response and cancer progression on prostate needle biopsy
-
Donovan MJ, Khan FM, Fernandez G, et al,. Personalized prediction of tumor response and cancer progression on prostate needle biopsy. J Urol 2009; 182: 125-32
-
(2009)
J Urol
, vol.182
, pp. 125-132
-
-
Donovan, M.J.1
Khan, F.M.2
Fernandez, G.3
-
10
-
-
2642548279
-
Natural history of early, localized prostate cancer
-
DOI 10.1001/jama.291.22.2713
-
Johansson JE, Andren O, Andersson SO, et al,. Natural history of early, localized prostate cancer. JAMA 2004; 291: 2713-9 (Pubitemid 38725420)
-
(2004)
Journal of the American Medical Association
, vol.291
, Issue.22
, pp. 2713-2719
-
-
Johansson, J.-E.1
Andren, O.2
Andersson, S.-O.3
Dickman, P.W.4
Holmberg, L.5
Magnuson, A.6
Adami, H.-O.7
-
11
-
-
17844402699
-
20-Year outcomes following conservative management of clinically localized prostate cancer
-
DOI 10.1001/jama.293.17.2095
-
Albertsen PC, Hanley JA, Fine J,. 20-year outcomes following conservative management of clinically localized prostate cancer. JAMA 2005; 293: 2095-101 (Pubitemid 40617061)
-
(2005)
Journal of the American Medical Association
, vol.293
, Issue.17
, pp. 2095-2101
-
-
Albertsen, P.C.1
Hanley, J.A.2
Fine, J.3
-
12
-
-
33750455445
-
Long-term outcome among men with conservatively treated localised prostate cancer
-
DOI 10.1038/sj.bjc.6603411, PII 6603411
-
Cuzick J, Fisher G, Kattan MW, et al,. Long-term outcome among men with conservatively treated localized prostate cancer. Br J Cancer 2006; 95: 1186-94 (Pubitemid 44658482)
-
(2006)
British Journal of Cancer
, vol.95
, Issue.9
, pp. 1186-1194
-
-
Cuzick, J.1
Fisher, G.2
Kattan, M.W.3
Berney, D.4
Oliver, T.5
Foster, C.S.6
Moller, H.7
Reuter, V.8
Fearn, P.9
Eastham, J.10
Scardino, P.11
-
13
-
-
62549130773
-
Ki67 and outcome in clinically localized prostate cancer: Analysis of conservatively treated prostate cancer patients from the Trans-Atlantic Prostate Group study
-
Berney DM, Gopalan A, Kudahetti S, et al,. Ki67 and outcome in clinically localized prostate cancer: analysis of conservatively treated prostate cancer patients from the Trans-Atlantic Prostate Group study. Br J Cancer 2009; 100: 888-93
-
(2009)
Br J Cancer
, vol.100
, pp. 888-893
-
-
Berney, D.M.1
Gopalan, A.2
Kudahetti, S.3
-
14
-
-
66749147047
-
Support vector regression for censored data [SVRc]: A novel tool for survival analysis. Proceedings of the Eighth IEEE international conference on data mining
-
Khan FM, Bayer-Zubek V,. Support vector regression for censored data [SVRc]: a novel tool for survival analysis. Proceedings of the Eighth IEEE international conference on data mining. ICDM 2008; 50: 863-8
-
(2008)
ICDM
, vol.50
, pp. 863-868
-
-
Khan, F.M.1
Bayer-Zubek, V.2
-
15
-
-
34547774187
-
Contemporary Trends in Low Risk Prostate Cancer: Risk Assessment and Treatment
-
DOI 10.1016/j.juro.2007.03.135, PII S0022534707008233
-
Cooperberg MR, Broering JM, Kantoff PW, Carroll PR,. Contemporary trends in low risk prostate cancer: risk assessment and treatment. J Urol 2007; 178: S14-9 (Pubitemid 47224952)
-
(2007)
Journal of Urology
, vol.178
, Issue.SUPPL.
-
-
Cooperberg, M.R.1
Broering, J.M.2
Kantoff, P.W.3
Carroll, P.R.4
-
16
-
-
77951298954
-
Randomized trial results did not resolve controversies surrounding prostate cancer screening
-
Hoffman RM,. Randomized trial results did not resolve controversies surrounding prostate cancer screening. Curr Opin Urol 2010; 20: 189-93
-
(2010)
Curr Opin Urol
, vol.20
, pp. 189-193
-
-
Hoffman, R.M.1
-
17
-
-
51049104630
-
Radical prostatectomy versus watchful waiting in localized prostate cancer: The Scandinavian prostate cancer group-4 randomized trial
-
Bill-Axelson A, Holmberg L, Filen F, et al,. Radical prostatectomy versus watchful waiting in localized prostate cancer: the Scandinavian prostate cancer group-4 randomized trial. J Natl Cancer Inst 2008; 100: 1144-54
-
(2008)
J Natl Cancer Inst
, vol.100
, pp. 1144-1154
-
-
Bill-Axelson, A.1
Holmberg, L.2
Filen, F.3
-
18
-
-
37448998966
-
Nomogram incorporating PSA level to predict cancer-specific survival for men with clinically localized prostate cancer managed without curative intent
-
Kattan MW, Cuzick J, Fisher G, et al,. Nomogram incorporating PSA level to predict cancer-specific survival for men with clinically localized prostate cancer managed without curative intent. Cancer 2008; 112: 69-74
-
(2008)
Cancer
, vol.112
, pp. 69-74
-
-
Kattan, M.W.1
Cuzick, J.2
Fisher, G.3
-
19
-
-
23744485107
-
Androgen receptor, Ki67, and p53 expression in radical prostatectomy specimens predict treatment failure in Japanese population
-
DOI 10.1016/j.urology.2005.02.028, PII S0090429505003055
-
Inoue T, Segawa T, Shiraishi T, et al,. Androgen receptor, Ki67, and p53 expression in radical prostatectomy specimens predict treatment failure in Japanese population. Urology 2005; 66: 332-7 (Pubitemid 41138093)
-
(2005)
Urology
, vol.66
, Issue.2
, pp. 332-337
-
-
Inoue, T.1
Segawa, T.2
Shiraishi, T.3
Yoshida, T.4
Toda, Y.5
Yamada, T.6
Kinukawa, N.7
Kinoshita, H.8
Kamoto, T.9
Ogawa, O.10
-
20
-
-
0031689226
-
Ki67 labeling index in core needle biopsies independently predicts tumor-specific survival in prostate cancer
-
DOI 10.1016/S0046-8177(98)90199-X
-
Bubendorf L, Tapia C, Gasser TC, et al,. Ki67 labeling index in core needle biopsies independently predicts tumor-specific survival in prostate cancer. Hum Pathol 1998; 29: 949-54 (Pubitemid 28422042)
-
(1998)
Human Pathology
, vol.29
, Issue.9
, pp. 949-954
-
-
Bubendorf, L.1
Tapia, C.2
Gasser, T.C.3
Casella, R.4
Grunder, B.5
Moch, H.6
Mihatsch, M.J.7
Sauter, G.8
-
21
-
-
0034614097
-
Expression of nuclear antigen Ki-67 in prostate cancer needle biopsy and radical prostatectomy specimens
-
Mucci NR, Rubin MA, Strawderman MS, Montie JE, Smith DC, Pienta KJ,. Expression of nuclear antigen Ki-67 in prostate cancer needle biopsy and radical prostatectomy specimens. J Natl Cancer Inst 2000; 92: 1941-2 (Pubitemid 32036925)
-
(2000)
Journal of the National Cancer Institute
, vol.92
, Issue.23
, pp. 1941-1942
-
-
Mucci, N.R.1
Rubin, M.A.2
Strawderman, M.S.3
Montie, J.E.4
Smith, D.C.5
Pienta, K.J.6
-
22
-
-
2942644682
-
Ki-67 staining is a strong predictor of distant metastasis and mortality for men with prostate cancer treated with radiotherapy plus androgen deprivation: Radiation Therapy Oncology Group trial 92-02
-
DOI 10.1200/JCO.2004.09.150
-
Pollack A, DeSilvio M, Khor LY, et al,. Ki-67 staining is a strong predictor of distant metastasis and mortality for men with prostate cancer treated with radiotherapy plus androgen deprivation: Radiation Therapy Oncology Group Trial 92-02. J Clin Oncol 2004; 22: 2133-40 (Pubitemid 41095146)
-
(2004)
Journal of Clinical Oncology
, vol.22
, Issue.11
, pp. 2133-2140
-
-
Pollack, A.1
Desilvio, M.2
Khor, L.-Y.3
Li, R.4
Al-Saleem, T.I.5
Hammond, M.E.6
Venkatesan, V.7
Lawton, C.A.8
Roach III, M.9
Shipley, W.U.10
Hanks, G.E.11
Sandler, H.M.12
-
23
-
-
33845942048
-
Expression of Ki-67, cyclin D1 and apoptosis markers correlated with survival in prostate cancer patients treated by radical prostatectomy
-
Aaltomaa S, Karja V, Lipponen P, et al,. Expression of Ki-67, cyclin D1 and apoptosis markers correlated with survival in prostate cancer patients treated by radical prostatectomy. Anticancer Res 2006; 26: 4873-8 (Pubitemid 46032126)
-
(2006)
Anticancer Research
, vol.26
, Issue.C
, pp. 4873-4878
-
-
Aaltomaa, S.1
Karja, V.2
Lipponen, P.3
Isotalo, T.4
Kankkunen, J.-P.5
Talja, M.6
Mokka, R.7
-
24
-
-
5144228549
-
High levels of phosphorylated form of Akt-1 in prostate cancer and non-neoplastic prostate tissues are strong predictors of biochemical recurrence
-
DOI 10.1158/1078-0432.CCR-04-0477
-
Ayala G, Thompson T, Yang G, et al,. High levels of phosphorylated form of Akt-1 in prostate cancer and non-neoplastic prostate tissues are strong predictors of biochemical recurrence. Clin Cancer Res 2004; 10: 6572-8 (Pubitemid 39346553)
-
(2004)
Clinical Cancer Research
, vol.10
, Issue.19
, pp. 6572-6578
-
-
Ayala, G.1
Thompson, T.2
Yang, G.3
Frolov, A.4
Li, R.5
Scardino, P.6
Ohori, M.7
Wheeler, T.8
Harper, W.9
-
25
-
-
3442891477
-
473) is an excellent predictor of poor clinical outcome in prostate cancer
-
DOI 10.1158/0008-5472.CAN-04-0272
-
Kreisberg JI, Malik SN, Prihods TJ, et al,. Phosphorylation of Akt [Ser473] is an excellent predictor of poor clinical outcome in prostate cancer. Cancer Res 2004; 64: 5232-6 (Pubitemid 39006542)
-
(2004)
Cancer Research
, vol.64
, Issue.15
, pp. 5232-5236
-
-
Kreisberg, J.I.1
Malik, S.N.2
Prihoda, T.J.3
Bedolla, R.G.4
Troyer, D.A.5
Kreisberg, S.6
Ghosh, P.M.7
-
26
-
-
34447133479
-
Determining risk of biochemical recurrence in prostate cancer by immunohistochemical detection of PTEN expression and Akt activation
-
DOI 10.1158/1078-0432.CCR-07-0091
-
Bedolla R, Prihoda TJ, Kreisberg JI, et al,. Determining risk of biochemical recurrence in prostate cancer by immunohistochemical detection of PTEN expression and Akt activation. Clin Cancer Res 2007; 13: 3860-7 (Pubitemid 47037592)
-
(2007)
Clinical Cancer Research
, vol.13
, Issue.13
, pp. 3860-3867
-
-
Bedolla, R.1
Prihoda, T.J.2
Kreisberg, J.I.3
Malik, S.N.4
Krishnegowda, N.K.5
Troyer, D.A.6
Ghosh, P.M.7
-
27
-
-
34547838420
-
PTEN, more than the AKT pathway
-
DOI 10.1093/carcin/bgm052
-
Blanco-Aparicio C, Renner O, Leal JF, Carnero A,. PTEN, more than the AKT pathway. Carcinogenesis 2007; 28: 1379-86 (Pubitemid 47243536)
-
(2007)
Carcinogenesis
, vol.28
, Issue.7
, pp. 1379-1386
-
-
Blanco-Aparicio, C.1
Renner, O.2
Leal, J.F.M.3
Carnero, A.4
-
28
-
-
77951723424
-
Molecular sampling of prostate cancer: A dilemma for predicting disease progression
-
Sboner A, Demichelis F, Calza S, et al,. Molecular sampling of prostate cancer: a dilemma for predicting disease progression. BMC Med Genomics 2010; 3: 2-12
-
(2010)
BMC Med Genomics
, vol.3
, pp. 2-12
-
-
Sboner, A.1
Demichelis, F.2
Calza, S.3
-
29
-
-
40849113286
-
Phosphorylation of the androgen receptor is associated with reduced survival in hormone-refractory prostate cancer patients
-
DOI 10.1038/sj.bjc.6604152, PII 6604152
-
McCall P, Gemmell LK, Mukherjee R, Bartlett JM, Edwards J,. Phosphorylation of the androgen receptor is associated with reducedsurvival in hormone-refractory prostate cancer patients. Br J Cancer 2008; 98: 1094-101 (Pubitemid 351399795)
-
(2008)
British Journal of Cancer
, vol.98
, Issue.6
, pp. 1094-1101
-
-
McCall, P.1
Gemmell, L.K.2
Mukherjee, R.3
Bartlett, J.M.S.4
Edwards, J.5
|